Document is current
Any future updates will be listed below
-
Authors
,
Zhang, Xiaoling http://orcid.org/0000-0001-8237-1857
van Rooij, Jeroen G. J.
Wakabayashi, Yoshiyuki
Hwang, Shih-Jen
Yang, Yanqin
Ghanbari, Mohsen
Bos, Daniel
Levy, Daniel
Johnson, Andrew D.
van Meurs, Joyce B. J.
Kavousi, Maryam
Zhu, Jun
O’Donnell, Christopher J.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (N01-HC-25195)
- License Information
-
More Information
Article History
Received: 11 February 2020
Accepted: 29 November 2020
First Online: 10 February 2021
Ethics approval and consent to participate
: Study protocol was approved by the Framingham Heart Study Ethics Committee. Written informed consent was obtained from each enrolled participant.
: Not Applicable.
: The authors declare no competing financial interests.The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the U.S. Department of Health and Human Services.This work was performed within the framework of the Biobank-Based Integrative Omics Studies (BIOS) Consortium funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007). The Rotterdam study is funded by the Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam.
